Unknown

Dataset Information

0

Olverembatinib inhibits SARS-CoV-2-Omicron variant-mediated cytokine release in human peripheral blood mononuclear cells.


ABSTRACT: The N-terminus domain (NTD) of the SARS-CoV-2 Omicron variant spike protien strongly induces multiple inflammatory molecules in human peripheral blood mononuclear cells, unaffected by the mutations observed in the NTD. Olverembatinib, a clinical-stage multi-kinase inhibitor, potently inhibits Omicron NTD-mediated cytokine release.

SUBMITTER: Chan M 

PROVIDER: S-EPMC9174875 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Olverembatinib inhibits SARS-CoV-2-Omicron variant-mediated cytokine release in human peripheral blood mononuclear cells.

Chan Marina M   Holland Eric C EC   Gujral Taranjit S TS  

EMBO molecular medicine 20220517 6


The N-terminus domain (NTD) of the SARS-CoV-2 Omicron variant spike protien strongly induces multiple inflammatory molecules in human peripheral blood mononuclear cells, unaffected by the mutations observed in the NTD. Olverembatinib, a clinical-stage multi-kinase inhibitor, potently inhibits Omicron NTD-mediated cytokine release. ...[more]

Similar Datasets

| EMPIAR-11180 | biostudies-other
| EMPIAR-11179 | biostudies-other
| S-EPMC8785151 | biostudies-literature
| EMPIAR-11176 | biostudies-other
| EMPIAR-11177 | biostudies-other
| EMPIAR-10947 | biostudies-other
2022-07-01 | GSE203030 | GEO
| EMPIAR-11871 | biostudies-other
| S-EPMC8693031 | biostudies-literature
| S-EPMC10256591 | biostudies-literature